ABC was created in spring 2020 in direct response to unprecedented challenges of the covid 19 pandemic and grew into the largest pandemic lab conducting up to 30% of total testing with public health contracts exceeding USD 180 million and R&D that led to three national screening programs and 9 publications. Now, we are deploying that infrastructure to the highly regulated, highly complex, and fragmented value chain for substance abuse testing at workplaces that is growing at more than 10% CAGR across the EU with need for increasingly sophisticated and scalable solutions to meet its challenges.